Work

Abstract 7220: Zongertinib demonstrates potent efficacy against cancer cells harboring HER2 non-tyrosine kinase domain mutations

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-7220

Authors: Yuji Shibata, Monique B. Nilsson, Hibiki Udagawa, Jacqulyne P. Robichaux, Junqin He, Xiaoxing Yu, John V. Heymach

Institutions: The University of Texas MD Anderson Cancer Center, National Cancer Center Hospital East

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409652528

Cites:

Cited by: 1

Related to: 10